Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00139360
Recruitment Status : Completed
First Posted : August 31, 2005
Last Update Posted : August 27, 2015
Norwegian Cancer Society
Hoffmann-La Roche
Information provided by (Responsible Party):
Oddbjørn Straume, MD PhD, Haukeland University Hospital